News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
690,920 Results
Type
Article (56094)
Company Profile (780)
Press Release (634028)
Multimedia
Podcasts (127)
Webinars (12)
Section
Business (184347)
Career Advice (2578)
Deals (33415)
Drug Delivery (111)
Drug Development (75026)
Employer Resources (132)
FDA (15848)
Job Trends (15680)
News (316728)
Policy (30995)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2806)
Academic (1)
Accelerated approval (31)
Adcomms (20)
Allergies (144)
Alliances (45001)
ALS (175)
Alzheimer's disease (1691)
Antibody-drug conjugate (ADC) (312)
Approvals (16115)
Artificial intelligence (530)
Autoimmune disease (156)
Automation (37)
Bankruptcy (287)
Best Places to Work (12309)
BIOSECURE Act (19)
Biosimilars (171)
Biotechnology (459)
Bladder cancer (159)
Brain cancer (60)
Breast cancer (657)
Cancer (4878)
Cardiovascular disease (408)
Career advice (2150)
Career pathing (34)
CAR-T (288)
CDC (53)
Celiac Disease (2)
Cell therapy (769)
Cervical cancer (38)
Clinical research (64299)
Collaboration (1769)
Company closure (2)
Compensation (1171)
Complete response letters (55)
COVID-19 (2526)
CRISPR (94)
C-suite (864)
Cystic fibrosis (151)
Data (6314)
Decentralized trials (1)
Denatured (14)
Depression (140)
Diabetes (488)
Diagnostics (6982)
Digital health (46)
Diversity (7)
Diversity, equity & inclusion (25)
Drug discovery (256)
Drug pricing (184)
Drug shortages (24)
Duchenne muscular dystrophy (226)
Earnings (76140)
Editorial (56)
Employer branding (19)
Employer resources (116)
Events (116148)
Executive appointments (1031)
FDA (19043)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (23)
Funding (1515)
Gene editing (199)
Generative AI (43)
Gene therapy (601)
GLP-1 (922)
Government (4513)
Grass and pollen (8)
Guidances (385)
Healthcare (20328)
HIV (57)
Huntington's disease (42)
IgA nephropathy (80)
Immunology and inflammation (235)
Immuno-oncology (57)
Indications (103)
Infectious disease (2786)
Inflammatory bowel disease (199)
Inflation Reduction Act (14)
Influenza (112)
Intellectual property (247)
Interviews (438)
IPO (16826)
IRA (51)
Job creations (3828)
Job search strategy (1850)
JPM (57)
Kidney cancer (15)
Labor market (73)
Layoffs (518)
Leadership (32)
Legal (6858)
Liver cancer (93)
Longevity (14)
Lung cancer (643)
Lymphoma (370)
Machine learning (43)
Management (50)
Manufacturing (800)
MASH (160)
Medical device (14502)
Medtech (14556)
Mergers & acquisitions (17760)
Metabolic disorders (1225)
Multiple sclerosis (158)
NASH (21)
Neurodegenerative disease (313)
Neuropsychiatric disorders (86)
Neuroscience (2933)
Neurotech (1)
NextGen: Class of 2026 (7333)
Non-profit (4977)
Now hiring (41)
Obesity (557)
Opinion (291)
Ovarian cancer (164)
Pain (215)
Pancreatic cancer (231)
Parkinson's disease (289)
Partnered (27)
Patents (490)
Patient recruitment (494)
Peanut (58)
People (56582)
Pharmaceutical (136)
Pharmacy benefit managers (27)
Phase 1 (19991)
Phase 2 (27942)
Phase 3 (21649)
Pipeline (5161)
Policy (283)
Postmarket research (2476)
Preclinical (8670)
Press Release (68)
Prostate cancer (241)
Psychedelics (48)
Radiopharmaceuticals (295)
Rare diseases (840)
Real estate (6365)
Recruiting (59)
Regulatory (24107)
Reports (38)
Research institute (2591)
Resumes & cover letters (416)
Rett syndrome (28)
RNA editing (14)
RSV (70)
Schizophrenia (151)
Series A (252)
Series B (195)
Service/supplier (26)
Sickle cell disease (97)
Special edition (23)
Spinal muscular atrophy (147)
Sponsored (35)
Startups (3478)
State (2)
Stomach cancer (13)
Supply chain (106)
Tariffs (87)
The Weekly (111)
Vaccines (946)
Venture capital (86)
Weight loss (351)
Women's health (74)
Worklife (15)
Date
Today (22)
Last 7 days (628)
Last 30 days (2060)
Last 365 days (31289)
2026 (2987)
2025 (31744)
2024 (36566)
2023 (41339)
2022 (50290)
2021 (55555)
2020 (55734)
2019 (49736)
2018 (37124)
2017 (31579)
2016 (30280)
2015 (35648)
2014 (28400)
2013 (28092)
2012 (24403)
2011 (24706)
2010 (23232)
Location
Africa (860)
Alabama (89)
Alaska (6)
Arizona (248)
Arkansas (14)
Asia (40568)
Australia (7266)
California (11533)
Canada (3248)
China (1145)
Colorado (483)
Connecticut (503)
Delaware (346)
Europe (93769)
Florida (1704)
Georgia (372)
Hawaii (4)
Idaho (64)
Illinois (905)
India (63)
Indiana (540)
Iowa (23)
Japan (429)
Kansas (126)
Kentucky (43)
Louisiana (30)
Maine (83)
Maryland (1447)
Massachusetts (8494)
Michigan (343)
Minnesota (664)
Mississippi (6)
Missouri (139)
Montana (32)
Nebraska (28)
Nevada (126)
New Hampshire (85)
New Jersey (3110)
New Mexico (28)
New York (3055)
North Carolina (1606)
North Dakota (10)
Northern California (5569)
Ohio (352)
Oklahoma (23)
Oregon (55)
Pennsylvania (2311)
Puerto Rico (23)
Rhode Island (50)
South America (1171)
South Carolina (67)
South Dakota (1)
Southern California (4480)
Tennessee (176)
Texas (1799)
United States (41433)
Utah (346)
Vermont (1)
Virginia (290)
Washington D.C. (82)
Washington State (981)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
690,920 Results for "new england biolabs inc.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
New England Biolabs® and Inorevia to partner on novel solutions for the preparation of challenging samples for next generation sequencing
New England Biolabs (NEB ®) and Inorevia announce a collaboration to develop automated workflows to maximize data quality by preparation of sequence-ready libraries from challenging samples using NEBNext® library preparation reagents on Inorevia’s Magelia® automation platform.
June 18, 2024
·
4 min read
Press Releases
AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine
January 15, 2026
·
9 min read
Press Releases
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)
December 30, 2025
·
12 min read
Press Releases
Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting
November 24, 2025
·
3 min read
Press Releases
Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease
December 8, 2025
·
6 min read
Press Releases
New England Journal of Medicine Publishes Phase 3 ASCENT-04/KEYNOTE-D19 Results Supporting Trodelvy® Plus Keytruda® as a Potential New Standard of Care in First-line PD-L1+ Metastatic Triple-negative Breast Cancer
January 22, 2026
·
17 min read
Press Releases
Talus Bio Announces New Collaboration with PRISM BioLab to Discover Novel Modulators of Transcription Factor and Protein-Protein Interaction Targets
December 18, 2025
·
4 min read
Press Releases
Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years
December 8, 2025
·
11 min read
Press Releases
Imbed Biosciences Secures Strategic Investment from BioLab Holdings
February 4, 2026
·
2 min read
Press Releases
The New England Journal of Medicine Publishes Positive Phase 3 VALIANT Results of EMPAVELI® (pegcetacoplan) for C3G and Primary IC-MPGN
December 4, 2025
·
13 min read
1 of 69,092
Next
